Overview of Segmentation, Market Dynamics, and Competitive Landscape in the Cell Viability Assays Market

The cell viability assays market is gaining considerable attention as advancements in biotechnology and pharmaceutical research accelerate. With increasing demand for precise and efficient testing methods, this market is poised for significant expansion in the coming years. Let's explore the current market size, key players, driving factors, trends, and segmentations shaping the future of cell viability assays.

Projected Market Expansion of the Cell Viability Assays Market Through 2030
The cell viability assays market is set for robust growth, anticipated to reach a valuation of $2.72 billion by 2030. This growth reflects a compound annual growth rate (CAGR) of 9.3% over the forecast period. Several factors are fueling this rise, including the growing need for high-throughput drug discovery, the widespread adoption of automated assay platforms, and the expanding scope of personalized medicine research. Additional contributors include a focus on assay miniaturization and the increasing incorporation of imaging-based viability analysis techniques. Notable trends expected to influence the market include a surge in high-sensitivity viability assays, broader use of microplate-based detection systems, rising interest in multiparametric cell health analysis, a widening range of drug screening applications, and a stronger emphasis on reproducible assay protocols.

Download a free sample of the cell viability assays market report:
https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Leading Organizations Driving the Cell Viability Assays Industry Forward
The cell viability assays market features a diverse group of influential companies, including Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, dic*kinson, and Company, Agilent Technologies Inc., Lonza Group Ltd., PerkinElmer Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Beckman Coulter Inc., Promega Corporation, Abcam Limited, MP Biomedicals, Cayman Chemical Company, Cell Signaling Technology Inc., Enzo Biochem Inc., Creative Bioarray, Abnova Corporation, Biotium, Canvax, Nexcelom Bioscience LLC, G-Biosciences, and AAT Bioquest Inc. These companies play pivotal roles in advancing assay technologies and expanding market reach.

Strategic Acquisition Enhances Market Capabilities of Fluidic Sciences
In September 2025, Fluidic Sciences, a US-based life sciences enterprise, acquired Sphere Bio's business and assets for an undisclosed amount. Sphere Bio, also based in the US, is known for its specialization in cell viability assays manufacturing. This acquisition is expected to accelerate Fluidic Sciences' capabilities in single-cell analysis and protein interaction research. The move will broaden Fluidic Sciences' technology portfolio, strengthen its position in the biopharmaceutical and biotechnology sectors, and enhance its research offerings significantly.

The cell viability assays market is gaining considerable attention as advancements in biotechnology and pharmaceutical research accelerate. With increasing demand for precise and efficient testing methods, this market is poised for significant expansion in the coming years. Let's explore the current market size, key players, driving factors, trends, and segmentations shaping the future of cell viability assays.

Projected Market Expansion of the Cell Viability Assays Market Through 2030
The cell viability assays market is set for robust growth, anticipated to reach a valuation of $2.72 billion by 2030. This growth reflects a compound annual growth rate (CAGR) of 9.3% over the forecast period. Several factors are fueling this rise, including the growing need for high-throughput drug discovery, the widespread adoption of automated assay platforms, and the expanding scope of personalized medicine research. Additional contributors include a focus on assay miniaturization and the increasing incorporation of imaging-based viability analysis techniques. Notable trends expected to influence the market include a surge in high-sensitivity viability assays, broader use of microplate-based detection systems, rising interest in multiparametric cell health analysis, a widening range of drug screening applications, and a stronger emphasis on reproducible assay protocols.

Download a free sample of the cell viability assays market report:
https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Apr_PR
Leading Organizations Driving the Cell Viability Assays Industry Forward
The cell viability assays market features a diverse group of influential companies, including Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, dic*kinson, and Company, Agilent Technologies Inc., Lonza Group Ltd., PerkinElmer Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Beckman Coulter Inc., Promega Corporation, Abcam Limited, MP Biomedicals, Cayman Chemical Company, Cell Signaling Technology Inc., Enzo Biochem Inc., Creative Bioarray, Abnova Corporation, Biotium, Canvax, Nexcelom Bioscience LLC, G-Biosciences, and AAT Bioquest Inc. These companies play pivotal roles in advancing assay technologies and expanding market reach.

Strategic Acquisition Enhances Market Capabilities of Fluidic Sciences
In September 2025, Fluidic Sciences, a US-based life sciences enterprise, acquired Sphere Bio's business and assets for an undisclosed amount. Sphere Bio, also based in the US, is known for its specialization in cell viability assays manufacturing. This acquisition is expected to accelerate Fluidic Sciences' capabilities in single-cell analysis and protein interaction research. The move will broaden Fluidic Sciences' technology portfolio, strengthen its position in the biopharmaceutical and biotechnology sectors, and enhance its research offerings significantly.

Emerging Trends in the Cell Viability Assays Market
Key players in the market are focusing on innovation by developing lightweight, ergonomic, and high-performance solutions that improve efficiency, precision, and workflow in laboratory settings. Such designs are tailored to ease handling, reduce operator fatigue, and produce consistent, high-quality assay results. For example, in March 2023, GPAINNOVA, a dental technology company based in Spain, introduced the DLyte Mini-the lightest polishing machine for dental laboratories. This device streamlines workflow, enhances precision, and supports advanced manufacturing techniques by ensuring superior surface finishing for dental restorations. Although this example focuses on dental polishing machines, it reflects a broader industry trend toward ergonomic and efficient laboratory equipment that can impact cell viability assay processes as well.

Detailed Breakdown of the Global Cell Viability Assays Market
This report segments the cell viability assays market into several categories to provide a clear understanding of its scope:
1) By Product Type: Consumables and Instruments
2) By Application: Basic Research, Stem Cell Research, Drug Discovery and Development, Clinical and Diagnostic Applications, and Other Applications
3) By End-User: Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospital and Diagnostic Laboratories, and Other End-Users

Further subsegments include:
- Consumables: Reagents, Kits, Assay Plates (such as 96-well plates), and Microplates
- Instruments: Spectrophotometers, Fluorometers, Microplate Readers, Flow Cytometers, and Imaging Systems

These classifications offer a comprehensive view of the market's components and help identify growth opportunities across different sectors and technologies.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.